Meta-analysis about Western Medicine combined with activating blood drugs on modulating blood glucose and lipids in diabetic patients

OBJECTIVE： To assess the effect of activating blood drugs （AB drugs） on blood glucose and lipid levels of diabetic patients METHODS： Systematic searches were conducted on 6 electronic databases and the search time was cut off in May 2016. Randomized controlled trials （RCTs） were included if they investigated diabetic patients who received Western medicine combined withAB drugs in the experimental groups and solitary usage of corresponding Western medicine or placebo in the control groups. 6 outcome measures, which were considered as inclusion, were changes in fasting blood glucose （FBG）, glycosylated haemoglobin A1 c （HbA 1 c）, total triglyceride （TG）, total cholesterol （TC）, low density lipoprotein cholesterol （LDL-c） and high density lipoprotein cholesterol （HDL-c）. The literature quality was assessed by Cochrane score for risk of bias in Review Manager 5.2, as well as meta-analysis was performed. RESULTS： 7 RCTs comprising 999 patients met all inclusion criteria. Meta-analysis showed beneficial effects of Western medicine combined with AB drugs on modulating FBG, TC, LDL-c and HDL-c compared with Western medicine or placebo （P〈0.05）, while no difference was observed in HbAlc, and TG （P〉0.05）. To some extent, the therapeutic effects of Western medicine combined with AB drugs were better than that of solitary usage of Western medicine or placebo. Besides, AB drugs were safe and reliable with little toxic and side-effects. CONCLUSIONS： The meta-analysis suggests beneficial effects of Western medicine combined with AB drugs on modulating blood glucose and lipids in diabetic patients.

Clinical Study on Effect of Chinese Herbal Medicine for Supplementing Kidney and Qi and Activating Blood Circulation in Treating Intrauterine Growth Retardation of Fetus

Objective: To explore the therapeutic effect and the possible working mechanism in using Chinese herbal medicine (CHM) for supplementing Kidney and Qi, and activating blood circulation in treating intrauterine growth retardation of fetus (IUGR). Methods: Fifty-five cases of IUGR were divided into two groups, 30 cases in the CHM group treated with CHM and the 25 in the control group treated with amino acids. The effect of CHM treatment was observed and compared with that of the control group, normal pregnancy group and non-treated IUGR group. Results: Body weight of the newborns in the CHM was markedly higher than that in the control group. Not only the maternal fundal height (FH) and the abdominal circumference (AC), but also the fetal growth parameters, including biparietal diameter, head circumference (HC), and femur length (FL) in the CHM group increased much faster than those in the control group. After CHM treatment, the maternal serum levels of estriol (E3) and human placental lactogen (hPL) approached to those in the normal pregnancy group, but the control group,in comparison with the normal pregnancy group, was significantly different. The umbilical venous plasma concentration of essential amino acids in both treated groups improved, but the improvement in the CHM group was more significant than that in the control group. No apparent adverse effect of CHM was observed in either mother or fetus.Conclusion: CHM for supplementing Kidney and Qi and activating blood circulation was more effective in improving placental function and enhancing amino acid transportation than amino acid

Effect of Chinese Herbal Medicine for Nourishing Yin,Supplementing Qi,and Activating Blood on the Th1/Th2 Immune Balance in Peripheral Blood in Patients with Primary Sjogren's Syndrome

Objective： To observe the effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the expression of interferen- γ （IFN-γ,）/interleukin-4 （IL-4） in peripheral blood and disease activity in primary Sjogren＇s syndrome （pSS） patients, and to study the relationship between the immune balance of Th1/Th2 and the disease activity. Methods： A total of 66 pSS patients were randomized with tossing coins method into two groups： the integrative therapy group （34 cases） and the control group （32 cases）; and 28 healthy subjects were taken as the normal group. The integrative therapy group was treated by Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood combined with hydroxychloroquine sulfate tablets and the control group was treated with hydroxychloroquine sulfate tablets. The treatment course was 3 months for both groups. The levels of serum immunoglobulin G （IgG）, erythrocyte sedimentation rate （ESR）, IFN-γand IL-4 in peripheral blood were measured before and after treatment. Results： Compared with the normal group, the levels of IgG, ESR, IFN- γ and IL-4 were significantly increased in pSS patients （P〈0.05）. Remarkably, after 3 months of treatment, these levels were dramatically decreased in both the integrative therapy group and the control group, although still higher than the normal group. The levels of IgG, ESR, IFN- and IL-4 in the integrative therapy group were lower than the control group and the same group before treatment （P〈0.05）. The ratio of IFN-γ/IL-4 also significantly decreased after treatment. Moreover, the level of IFN- γ, and the ratio of IFN- γ/IL-4 in the integrative theraphy group were significantly lower than the control group （P〈0.05）. For all patients the ratio of IFN-γ/IL-4 before and after treatment was positive correlated with the levels of IgG and ESR. Conclusion： Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood can alleviate the disease activity of pSS by regulating the immune balance of Th1/Th2.

Effect of Chinese Herbal Medicines for Nourishing Yin,Supplementing Qi,and Activating Blood on Reproductive Endocrine Activity and Immune Functions in Patients with Primary Sjogren's Syndrome

ABSTRACT Objective： To investigate the effect of Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood on the reproductive endocrine-immune network and its mechanisms in patients with primary Sjogren＇s syndrome （pSS）. Methods： Seventy pSS patients were randomly assigned to two groups using a randomized digital table： the integrative therapy group （36 cases） and the control group （34 cases）. Thirty healthy subjects were taken as a normal group. The control group was treated with hydroxychloroquine sulfate tablets alone, and the integrative therapy group was treated by Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood combined with hydroxychloroquine sulfate tablets. The treatment course was 6 months for both groups. Before and after treatment, serum estradiol （E2）, testosterone （T）, luteinizing hormone （LH）, prolactin （PRL） by radioimmunoassay and immunoglobulin （IgG） by immunodiffusion, erythrocyte sedimentation rate （ESR） by Westergren, interferon-γ （IFN-γ） and interleukin-4 （IL-4） by enzyme linked immunosorbent assay were determined. Results： E2 and T levels in all patients were lower than those of normal subjects before treatment （P〈0.05） and were increased significantly after 6-month treatment （P〈0.05）. ESR, FSH, LH, IgG, IFN - γ, IL - 4 and ratios of E2/T, and IFN --γ/IL in the patients were higher than those of normal subjects before the treatments （P〈0.05）, and were reduced significantly after the treatments （P〈0.05）. The T and IFN -γ levels and E2/T ratio in the patients treated with integrative therapy were reduced significantly compared with the control group （P〈0.05）. However, the PRL levels before and after treatment were not significantly changed in the two groups （P〉0.05）. The ratios of E2/T and IFN -γ/IL-4, and levels of IgG and ESR were positively correlated before and after treatment （P〈0.05）. Conclusions： The ratios of E2/T and IFN - γ/ IL-4 might be used as indicators of pSS activity. Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood combined with Western medicine could improve the therapeutic effect by regulating the reproductive endocrine-immune network in pSS patients.

Mechanism of Erhuang capsule for treatment of multiple sclerosis

Erhuang capsule, a typical formula based on traditional Chinese medicine theory, is widely used to ameliorate multiple sclerosis, inflammation and side effects of glucocortJcoid treatment. Oligodendrocyte precursor cells are neural stem cells that are important for myelin repair and regeneration. In the present study, Erhuang capsule effectively improved clinical symptoms and neurological function scores, reduced mortality and promoted recovery of neurological functions of mice with experimental autoimmune encephalomyelitis. The mechanism of action involved significant increases in oligodendrocyte precursor cell proliferation in specific regions of the brain and spinal cord, increased oligodendrocyte lineage gene 2 expression and enhanced oligodendrocyte precursor cell differentiation.

Research Progress on the Pharmacological Mechanisms of Chinese Medicines that Tonify Qi and Activate Blood Against Cerebral Ischemia/Reperfusion Injury

Cerebral ischemia-reperfusion injury(CIRI) refers to a pathological phenomenon that aggravates the injury after the restoration of blood perfusion and oxygen supply to the cerebral ischemia-induced tissues and organs, with a relatively high incidence. The traditional Chinese medicine(TCM) believes that Qi deficiency and blood stasis are the cause of CIRI. Therefore, Chinese medicine for tonifying Qi and activating blood is regarded as an important choice for the treatment of CIRI. In recent years, it has been found that many Chinese herbal medical ingredients and compound Chinese medicine(CCM) have significant anti-CIRI effects, and their mechanisms of action mainly include improving brain blood supply, neuroprotection, regulating signal pathways such as TLR4/HO-1/Bcl-2, protecting mitochondrial function, regulating related protein levels, and regulating oxidative molecule levels. This article summarizes and introduces the pharmacological mechanisms of Tonifying-Qi and activating-blood Chinese medicine and CCM which have the function of anti-CIRI. Our goal is to provide effective reference for further researches on the cerebral protection of related TCMs or compounds and their clinical application.

Clinical Factors Affecting Platelet Growth in the Treatment of Aplastic Anemia by Tonifying Kidney and Generating Blood

Objective:To investigate the influence of kidney-tonifying and blood-generating method on platelet(PLT)growth in the treatment of aplastic anemia(AA)and analyze the characteristics of the clinical factors affecting PLT growth.We enrolled patients treated from September 2018to March 2021 in the China Academy of Traditional Chinese Medicine(TCM)Xiyuan Hospital,China Academy of TCM hospital gate 19sub-center.We enrolled 128 AA patients,for whom the inclusion criteria were:treatment is given priority to with kidney and heart's-blood method,on the basis of western medicine treatment for kidney fill party avoid Fried instant particles,stay for 3 months for a period of treatment,taking two consecutive period of treatment,changes in the PLT were observed,and the clinical characteristics of AA patients,such as PLT growth and recovery from baseline value,were analyzed.Materials and Methods:A total of 128 AA patients from 19 branches of Xiyuan Hospital,China Academy of Chinese Medical Sciences and Guang'anmen Hospital,China Academy of Chinese Medical Sciences treated from September 2018 to March 2021 were enrolled.The treatment was based on the kidney-tonifying and blood-generating method and lasted for 3 months as a course of treatment.The changes in the number of PLT in patients were observed,and the clinical characteristics of AA affecting PLT growth and recovery from baseline value were analyzed.Results:After 6 months of treatment following the kidney-tonifying and blood-generating method,PLT increased from the baseline values in 75 cases,including 21 cases of AA with normal PLT recovery and 54 cases of AA without normal PLT recovery.There were 53 cases of AA in whom PLT did not increase from the baseline.Analysis of the general data showed that patients with lower Karnofsky Performance Status(KPS)score were more likely to experience PLT growth or even return to normal after therapy(P<0.05).The results of routine blood analysis showed that when hemoglobin(HGB)was≥60 g/L and the reticulocyte(RET)proportion was≥0.3%before treatment,PLTs were more likely to increase,even returning to normal in some patients(P<0.05).Analysis of bone puncture results before treatment showed that when the proliferation of nucleated cells was low or extremely low in bone puncture examination,with the proportion of granulocytes<40%,and the proportion of erythroid cells<20%,the treatment method was more effective at increasing PLT count(P<0.05).Analysis of the chromosome karyotype results before treatment showed that when the chromosome karyotype was normal,PLTs were more likely to increase or even return to normal after treatment(P<0.05).Analysis of T-lymphocyte subsets before treatment showed that when CD3+human leukocyte antigen(HLA)-DR+proportion was≥30%,PLTs were more likely to increase or even return to normal(P<0.05).Conclusions:AA patients with a low KPS score,higher HGB≥60 g/L,RET proportion≥0.3%,low or extremely low proliferation of nucleated cells,granulocytes proportion<40%,erythroid proportion<20%,normal chromosome karyotype,CD3+HLA-DR+≥30%,should be treated with a kidney-tonifying and blood-generating method.Such patients are more likely to show PLT growth and the values may even return to normal.

郑惠芳教授采用补肾活血法提高薄型子宫内膜容受性的经验总结

郑惠芳教授系全国首批名老中医,临证经验丰富,擅用温补,尤其重用补肾。近几年子宫内膜容受性已经成为生殖医学领域研究的焦点问题,而补肾提高子宫内膜容受性在临床中得到普遍的应用,并且取得可喜的成果,其中中医药发挥了自己独特的优势。郑惠芳教授认为薄型内膜所致不孕的主要病机为肾精亏虚,精血不足,并提出补肾填精、活血养血为主要治疗原则,结合患者的具体情况,辨证论治,取得了显著的疗效,并提供了明确的辨证思路及治疗的方法。

骨质疏松症“亏瘀致痿”的理论构建及临床应用

骨质疏松症(OP)是一种以增龄性骨量降低,骨微结构破坏,骨脆性增加且易骨折的代谢性骨病。该病好发于绝经后女性和中老年男性,起病隐匿,多数患者在骨折后才被确诊,造成了大量的医疗资源消耗。浙江中医药大学附属第三医院姚新苗教授研究团队基于“肾主骨”“肾气虚损”等基础理论,创新性提出了OP“亏瘀致痿”的致病理论,认为OP的病机是亏虚瘀互结、夹杂致痿。在该理论指导下,认为应采用“补肾健脾活血法”对OP患者进行辨证论治。补肾健脾活血法主要包括虚瘀同治;补肾为本、健脾为要;筋骨并重3个方面。该研究团队开展了一系列临床与基础研究,从不同角度阐释“亏瘀致痿”理论指导下OP康复策略的科学内涵。

活血化瘀中药联合富血小板血浆改善激素性股骨头坏死的作用机制

背景:目前发现活血化瘀中药、富血小板血浆技术都能够修复受损血管,促进血管再生,重建股骨头内血运,恢复正常血供,进一步促进成骨作用,在早期干预激素性股骨头坏死方面均表现出一定的优势,可更加深入了解活血化瘀中药及富血小板血浆技术改善激素性股骨头坏死的作用机制,为今后治疗提供新思路。目的:根据国内外相关文献,综述活血化瘀中药联合富血小板血浆技术改善激素性股骨头坏死作用机制的研究进展。方法:检索PubMed、Web of Science、Metstr、中国知网及万方数据库收录的相关文献。以“中药、信号通路、激素性股骨头坏死、血管内皮生长因子、富血小板血浆”及“traditional Chinese medicine、signal pathways、steroid induced necrosis of femoral head、vascular endothelial growth factor、platelet rich plasma”分别作为中、英文检索词,检索文献时限为2000年1月至2022年7月,最终纳入相关文献75篇。结果与结论:活血化瘀中药及富血小板血浆技术在干预早期激素性股骨头坏死方面均表现出一定的优势。对于中医药而言,无论是活血化瘀单体药还是复方药都可以有效缓解激素性股骨头坏死疾病进一步发展,具体作用机制如下:①活血化瘀中药有显著抗凝作用,可以拮抗激素药物造成的血液异常(高凝)状态,进一步恢复股骨头内的正常血供;②活血化瘀中药可修复受损的血管内皮,通过激活血管内皮生长因子,使血管再生,重塑股骨头内血运;③活血化瘀中药祛瘀效果明显,可减少骨髓腔内的脂肪细胞堆积,缓解股骨头内压力;④活血化瘀中药可调控相关信号通路,维持骨代谢,促进成骨细胞、破骨细胞分化平衡,有效减轻激素性股骨头坏死。此外,富血小板血浆中含有大量高浓度细胞生长因子,对成骨作用及血管再生均起到正向作用,同时也可改善血液异常状态。活血化瘀中药联合富血小板血浆技术可发挥二者自身生物作用,干预效果更加显著。

益气活血法治疗慢性心力衰竭的数据挖掘与临床疗效

目的:通过数据挖掘,探索益气活血法治疗慢性心力衰竭(CHF)的用药规律和“药物-指标”关联关系,并回顾分析益气活血法的临床疗效。方法:选取2021年9月至2023年8月在安徽中医药大学第一附属医院心内科治疗CHF的患者病例资料,根据是否使用中药大于7 d,分为中药组和对照组,录入中药处方、检验和检查数据,使用聚类分析、关联分析、网络可视化等探索用药规律和“药物-指标”关联关系,运用倾向评分法、Kaplan-Meier法回顾中药治疗CHF的疗效。结果:共采集956例CHF患者的资料,其中785例中药组,对照组171例。对785首处方中出现频率前15名的药物进行聚类分析,发现治疗CHF的2组常用中药。第一组中药功在益气温阳,活血利水。第二组中药侧重于益气健脾,淡渗利湿。关联分析得到高频中药组合6对,进一步将“药物-疗效”进行关联分析发现,中药配伍与CHF相关指标的改善有较强的相关性。进行1∶1倾向性匹配,匹配出155对病例样本,统计结果显示,与西药常规治疗比较,使用中药明显降低肌酸激酶、B型脑钠肽、低密度脂蛋白胆固醇、C反应性蛋白、空腹血糖、收缩压和舒张压,显著升高高密度脂蛋白胆固醇水平、左室射血分数、24 h尿量。结论:中药益气活血法可提高CHF患者心功能,改善临床症状,提高生命质量。

基于隐结构模型结合关联规则探讨冠脉微血管疾病中医“症-证-药”规律

目的系统挖掘冠状动脉微血管疾病(Coronary microvascular disease,CMVD)中医常见症状、证候要素、临床辨证分型及用药规律,为量化CMVD临床辨证标准、规范中医临床证候诊断及疗效评价、指导临床用药提供参考依据。方法分别检索中国知网(CNKI)、万方数据库(Wanfang)、维普中文期刊(VIP)、中国生物医学文献服务系统(SinoMed)自建库至2023年5月16日有关中医药治疗CMVD的相关文献。提取纳入文献相关信息建立数据库并对症状、证素、证型、中药进行频数统计,分别采用Latern 5.0与Rstudio软件构建隐结构模型进行综合聚类与关联规则分析,探讨中医药治疗CMVD的症状特点、证素分布、常见证型及用药规律。结果共纳入107篇文献,涉及证型36个,证素17个,症状121个,中药143种,推测出CMVD的主要证候要素为血瘀,其次为气虚、气滞、痰浊、阴虚和阳虚;主要证型为气虚血瘀证,其次为心血瘀阻证、气滞血瘀证、痰瘀互结证、气阴两虚证等;用药以川芎、丹参、当归、黄芪为主;按功效分类主要为活血化瘀药、补虚药、理气药。结论CMVD病位在心,与肝、肾相关,属本虚标实之证,血瘀贯穿本病发展的始终;治疗以活血化瘀、通络止痛为主,并结合辨证选用补中益气、疏肝理气、祛痰散结等治法。

基于数据挖掘分析中医治疗中风后抑郁症配伍规律

目的运用数据挖掘方式探讨中医药治疗中风后抑郁(post-stroke depression,PSD)的用药规律,为临床诊疗提供一定的参考价值。方法检索中国知网(CNKI)、万方数据知识服务平台(万方数据)以及PubMed数据库自2012年7月1—2022年7月31日公开发表的关于中医药治疗PSD的临床研究文献,应用Microsoft Excel 2010建库,使用SPSS Modeler18.0、IBM SPSS Statistics 26.0统计软件进行频次、性味归经、关联、聚类规则分析。结果符合筛选标准文献95篇,中药134味,总使用频次1092次。其中15味药使用频次≥20次,药性以温、寒、平为主,温最甚;药味以甘、苦、辛为主,其中,甘味最多;归经以归肝、脾、肺、胃、肾、心经为主;使用频次为前5位的中药类别分别为解郁药、补虚药、活血化瘀药、安神药、理气药。运用Apriori算法得到常用关联药对,聚类分析得出8个聚类群。结论正虚是中风后抑郁的基础,在正虚的基础上伴有“瘀”与“郁”的病机特点,虚、瘀、郁贯穿于病程的各个阶段。临床多以解郁安神、温中补虚、活血行气为治疗原则,治疗多选用补虚药及归肝经的药物,以奏补虚化瘀、调畅气机之功,这为中风后抑郁的中医药治疗方案的制定提供了一定的参考价值。

雌二醇/雌二醇地屈孕酮片复方包装联合中医辨证治疗宫腔粘连的效果评价

目的分析宫腔粘连给予雌二醇/雌二醇地屈孕酮片复方包装联合中医辨证治疗的干预效果。方法回顾性选取2022年8月—2024年2月长春中医药大学附属医院收治的110例宫腔粘连患者的临床资料,根据治疗方法的不同分为对照组和观察组,各55例。对照组采用雌二醇/雌二醇地屈孕酮片复方包装治疗;观察组采取雌二醇/雌二醇地屈孕酮片复方包装联合中医辨证治疗。对比两组美国生育学会(American Fertility Society,AFS)评分、子宫血流及形态指标,纤维化指标以及不良反应发生情况。结果治疗后,两组AFS评分中的粘连累及范围、粘连类型、月经情况评分及总分均低于治疗前,且观察组低于对照组,差异有统计学意义(P均<0.05)。治疗后,两组血流阻力指数、搏动指数低于治疗前,且观察组低于对照组;治疗后两组患者的子宫内膜厚度高于治疗前,且观察组高于对照组,差异有统计学意义(P均<0.05)。治疗后两组转化因子β1、胰岛素生长因子1、基质金属蛋白酶抑制因子-1水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P均<0.05)。观察组不良反应发生率为3.64%(2/55),与对照组的9.09%(5/55)比较,差异无统计学意义(χ^(2)=1.248,P>0.05)。结论应用雌二醇/雌二醇地屈孕酮片复方包装联合中医辨证治疗宫腔粘连的临床效果良好,可以减小宫腔粘连累及范围、缓解粘连程度、改善月经情况,增加子宫内膜厚度,恢复子宫血流状态,抑制内膜组织纤维化,且不会增加用药风险。

基于补肾活血法探讨国医大师张大宁教授运用角药治疗慢性肾脏病的经验

慢性肾脏病是临床常见多发病,如果不及时有效治疗,其病情不断进展,最终可导致尿毒症,即终末期肾病。中医药在治疗慢性肾脏病方面有独特的优势,其治疗原则和方法与西医有所不同,注重整体调理和辨证施治。国医大师张大宁教授提出的“肾虚血瘀论”与“补肾活血法”是在长期临床实践基础上,针对慢性肾脏病的病理特点所形成的一种治疗策略。该理论认为,不同的致病因子所导致的不同疾病,发展到某一阶段,都会出现相同的病理改变,即“肾虚血瘀”;补肾活血法通过补肾促进活血,应用活血加强补肾,两者相互协同,达到改善肾虚血瘀病理变化。在该理论的指导下,临床治疗各类慢性肾脏疾病取得了显著疗效。同时,在临床用药中,三联药配伍法(角药)是张大宁教授的特色用药方法,做到升降并用,寒热并用,脏腑同治,攻补兼施,补中寓攻,攻中无损,相济为用,临床疗效显著。

益气活血通络汤联合替罗非班治疗进展性卒中临床观察

目的探讨益气活血通络汤联合替罗非班治疗进展性卒中(SIP)的效果。方法选取2020年5月—2022年5月九江市中医医院收治的60例SIP患者作为研究对象,按随机数字表法分为两组,各30例。对照组予以盐酸替罗非班氯化钠注射液治疗,观察组加用益气活血通络中药治疗,两组均治疗14 d。比较两组临床疗效、神经功能、改良Rankin量表(MRS)评分、洼田饮水试验评分、中医证候积分、血小板功能及安全性。结果观察组总有效率93.33%(28/30)高于对照组的73.33%(22/30)(P<0.05)。治疗后,观察组美国国立卫生研究院卒中量表(NIHSS)评分、MRS评分、洼田饮水试验评分低于对照组,半身不遂、偏身麻木、气短乏力、舌歪语謇证候积分低于对照组,差异有统计学意义(P<0.05);治疗后,观察组血小板聚集率、血小板黏附率低于对照组,差异有统计学意义(P<0.05)。结论益气活血通络汤联合替罗非班治疗SIP可增强临床效果、加快患者神经功能恢复、纠正血小板功能异常、降低中医证候积分,且安全可靠。

补肾活血调周法联合中药封包治疗宫腔粘连疗效观察及对PDGF-BB、TGF-β1、bFGF的影响

目的:观察补肾活血调周法联合中药封包治疗宫腔粘连(IUA)的临床疗效,以及对血小板源性生长因子(PDGF)-BB、转化生长因子-β1 (TGF-β1)及碱性成纤维细胞生长因子(bFGF)的影响。方法:选取40例行宫腔镜下宫腔粘连分离术治疗的IUA患者,采用随机数字表法分为对照组(应用补肾活血调周法治疗)及试验组(采用补肾活血调周法联合中药封包治疗),每组20例。2组均治疗3个月经周期,随访1年。比较2组临床疗效,子宫内膜厚度,子宫动脉血流参数[搏动指数(PI)、阻力指数(RI)],血清PDGF-BB、TGF-β1、bFGF水平,宫腔再粘连发生率及妊娠率。结果:治疗后,试验组总有效率85.00%,高于对照组55.00%(P<0.05)。2组子宫内膜厚度均较治疗前增加(P<0.05),PI、RI均较治疗前降低(P<0.05);试验组子宫内膜厚度大于对照组(P<0.05),PI、RI均低于对照组(P<0.05)。2组血清PDGF-BB、TGF-β1、bFGF水平均较治疗前降低(P<0.05),试验组血清PDGF-BB、TGF-β1、bFGF水平均低于对照组(P<0.05)。随访3个月,试验组再粘连发生率5.88%,低于对照组27.27%(P<0.05)。随访1年,试验组妊娠率40.00%,高于对照组5.00%(P<0.05)。结论:补肾活血调周法联合中药封包治疗IUA,可增加子宫内膜厚度,改善子宫动脉血流及临床症状,有效调节PDGF-BB、TGF-β1、bFGF水平,减少宫腔再粘连发生,提高妊娠率。

健脾活血利水方联合异甘草酸镁治疗失代偿期肝硬化临床研究

目的:观察健脾活血利水方联合异甘草酸镁治疗失代偿期肝硬化的临床疗效。方法:将184例失代偿期肝硬化患者按照随机数字表法分为对照组和试验组,每组各92例。对照组在常规对症及保肝治疗治疗的基础上给予异甘草酸镁注射剂,试验组在对照组治疗的基础上给予健脾活血利水方治疗。比较两组患者生活质量评分、临床疗效及不良反应发生情况,检测两组患者治疗前后血清丙氨酸转氨酶(alanine transaminase,ALT)及天冬氨酸转氨酶(aspartateaminotransferase,AST)水平。结果:试验组情感功能、系统症状、腹部症状等评分高于对照组(P<0.05)。两组患者治疗后ALT及AST低于本组治疗前,且治疗后试验组低于对照组(P<0.05)。对照组有效率为80.43%,试验组有效率为96.74%,两组有效率比较,差异具有统计学意义(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论:健脾活血利水方联合异甘草酸镁治疗失代偿期肝硬化,临床疗效确切,可提高患者的生活质量,改善其肝功能。

活血化瘀中药对鸡胚绒毛尿囊膜血管生成的影响

目的观察常用活血化瘀中药赤芍、当归、红花、川芎、丹参、黄芪及复方当归补血汤、血府逐瘀汤、芎芍胶囊等对鸡胚绒毛尿囊膜(chorioall antoic membrane,CAM)新生血管生成的影响。方法制备CAM模型,分别应用赤芍、当归、红花、川芎、丹参、黄芪及当归补血汤、血府逐瘀汤、芎芍胶囊的含药血清,观察CAM血管生成的情况,同时,设立生理盐水对照组、空白血清对照组、空白对照组及碱性成纤维细胞生长因子(basic fibroblast growth factor,bFGF)阳性对照组。结果所选药物及bFGF皆有促进CAM新生血管生成的作用,其中,丹参及当归补血汤、血府逐瘀汤、芎芍胶囊等复方在血管生成及血管计数方面,均明显优于生理盐水对照组、空白血清对照组及空白对照组,与阳性对照药bFGF的作用相当;中药复方的作用优于丹参之外的其他单味中药。结论活血化瘀中药丹参及当归补血汤、血府逐瘀汤、芎芍胶囊具有较好的促进CAM新生血管生成的作用。本实验从一个侧面阐明了活血化瘀中药及方剂治疗缺血性疾病的作用机理,同时,研究也体现了中药复方应用的科学依据。

补肾活血中药对大鼠骨髓间充质干细胞体外增殖的影响

目的观察补肾活血中药含药血清对大鼠骨髓间充质干细胞(MSCs)体外增殖的影响。方法采用Percoll密度梯度离心法分离纯化大鼠骨髓间充质干细胞,体外培养,建立大鼠骨髓间充质干细胞培养体系;收集补肾活血中药的含药血清,用10%含药血清代替10%的血清,绘制生长曲线,观察补肾活血中药含药血清促进骨髓间充质干细胞体外增殖的作用。结果所培养的大鼠骨髓细胞在表型表达和细胞形态上具备MSC特征,补肾活血中药含药血清组增长速度比空白对照组明显加快,并与剂量呈正比。结论补肾活血中药含药血清能促进干细胞在体外增殖。